Self‐assembled Fluorinated Nanoparticles as Sensitive and Biocompatible Theranostic Platforms for 19f Mri
Dominik Havlicek,Vyshakh M. Panakkal,Ludek Voska,Ondrej Sedlacek,Daniel Jirak
DOI: https://doi.org/10.1002/mabi.202300510
2024-01-14
Macromolecular Bioscience
Abstract:Theranostics is a novel paradigm integrating therapy and diagnostics, thereby providing new prospects for overcoming limitations of traditional treatments. In this context, perfluorocarbons (PFCs) are the most widely used tracers in preclinical fluorine‐19 magnetic resonance (19F MR), primarily for their high fluorine content. However, PFCs are extremely hydrophobic, and their solutions often display reduced biocompatibility, relative instability, and subpar 19F MR relaxation times. This study aims at exploring the potential of micellar 19F MRI tracers, synthesized by polymerization‐induced self‐assembly (PISA), as alternative theranostic agents for simultaneous imaging and release of the non‐steroidal antileprotic drug clofazimine. In vitro, under physiological conditions, these micelles demonstrate sustained drug release. In vivo, throughout the drug release process, they provide a highly specific and sensitive 19F magnetic resonance imaging (MRI) signal. Even after extended exposure, these fluoropolymer tracers show biocompatibility, as confirmed by our histological analysis. Moreover, the characteristics of these polymers can be broadly adjusted by design to meet the wide range of criteria for preclinical and clinical settings. Therefore, micellar 19F MRI tracers display physicochemical properties suitable for in vivo imaging, such as relaxation times and non‐toxicity, and high performance as drug carriers, highlighting their potential as both diagnostic and therapeutic tools. This article is protected by copyright. All rights reserved
materials science, biomaterials,polymer science,biochemistry & molecular biology